Armatus Bio, Inc.
| Armatus Bio is a preclinical stage company pioneering RNA interference gene therapies for neuromuscular diseases. Our lead assets are AAV delivered miRNA therapies for Charcot-Marie-Tooth Type 1A (CMT1A) and facioscapulohumeral muscular dystrophy (FSHD). |
